Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
Martineau AR, et al • BMJ
Key Finding
Overall ARTI reduction OR 0.88 (95% CI 0.81-0.96); daily/weekly dosing OR 0.81; profound deficiency (<25 nmol/L) + daily dosing OR 0.30 (NNT 4)
Key Findings
- 1Vitamin D supplementation reduced risk of acute respiratory infections by 12% overall
- 2Those with severe deficiency (<25 nmol/L) saw 70% reduction in respiratory infections
- 3Daily or weekly dosing was effective; large monthly boluses were not protective
- 4Individual participant data from 25 RCTs with 10,933 participants provided robust evidence
- 5Effect was consistent across age groups, countries, and baseline health status
Original title: “Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data”
Plain English Summary
IPD meta-analysis of 25 RCTs (11,321 participants) examining vitamin D supplementation for respiratory infection prevention. Greatest benefit in deficient individuals with daily/weekly dosing.
In-Depth Analysis
In 2017, a team led by Dr. Adrian Martineau at Queen Mary University of London published the definitive analysis of vitamin D supplementation for preventing respiratory infections. This landmark meta-analysis used individual participant data from 25 randomized controlled trials involving nearly 11,000 people.
Why Individual Participant Data Matters
Unlike typical meta-analyses that combine published summary statistics, Martineau's team obtained raw data from each trial. This allowed them to examine effects across subgroups that couldn't be analyzed from published papers alone—a much more powerful approach.
Key Findings
The overall results showed vitamin D supplementation reduced the risk of acute respiratory tract infections by 12% (adjusted odds ratio 0.88). But the benefits varied dramatically by baseline vitamin D status:
- •Severely deficient (<25 nmol/L): 70% reduction in infections
- •Moderately deficient (25-50 nmol/L): 25% reduction
- •Sufficient (>50 nmol/L): No significant benefit
Dosing Matters
Perhaps the most clinically important finding: how you take vitamin D matters as much as how much:
- •Daily or weekly dosing: Protective (19% reduction)
- •Monthly or less frequent boluses: Not protective
This suggests that maintaining steady vitamin D levels is more important than periodic high doses.
Biological Mechanism
Vitamin D enhances the innate immune response by stimulating production of antimicrobial peptides like cathelicidin and defensins. These peptides help destroy pathogens in the respiratory tract before they can cause infection.
Clinical Impact
This study provided the strongest evidence to date that correcting vitamin D deficiency can meaningfully reduce respiratory infections. During the COVID-19 pandemic, this research received renewed attention as scientists investigated potential protective effects against SARS-CoV-2.
The findings support routine vitamin D testing and supplementation, particularly for those at high risk of deficiency or frequent respiratory infections.
Paradigm Relevance
How this study applies to different clinical perspectives:
Standard Medical
RelevantConventional clinical guidelines used by most doctors
Why it matters:
Supports supplementation for deficient patients to prevent infections
Research Consensus
RelevantCurrent scientific understanding, often ahead of guidelines
Why it matters:
Key evidence for 40-60 ng/mL target to maximize immune benefit
Metabolic Optimization
RelevantProactive targets for optimal health, not just disease absence
Why it matters:
Foundation for higher-dose winter protocols and daily dosing preference
Study Details
- Type
- Meta-Analysis
- Methodology
- IPD meta-analysis. 25 RCTs. N = 11,321 (IPD obtained for 96.6%). Ages 0-95 years. GRADE: high quality evidence.
Evidence Quality
Grade A - IPD meta-analysis. PMC5310969. Landmark study establishing vitamin D role in respiratory immunity.
Calculate & Evaluate on Metabolicum
Original Source
DOI (Digital Object Identifier) is a permanent link to this publication. Unlike website URLs that can change, a DOI always resolves to the correct source.
Related Studies
Health Effects of Vitamin D supplementation: Lessons Learned from Randomized Controlled Trials and Mendelian Randomization Studies
Bouillon R, et al • J Bone Miner Res • 2023
Cancer mortality: daily dosing RR 0.88 (95% CI 0.78-0.98, 10 trials); bolus RR 1.07 (ineffective); VITAL: normal BMI cancer OR 0.76; shift focus to deficient individuals
Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials
Keum N, et al • Annals of Oncology • 2019
Cancer mortality: 13% reduction (RR 0.87, 95% CI 0.79-0.96, p=0.005); Cancer incidence: no effect (RR 0.98, 95% CI 0.93-1.03, p=0.42)
International Vitamin D Supplementation Guidelines
Pludowski P, et al • Journal of Steroid Biochemistry and Molecular Biology • 2018
Target 25(OH)D levels of 30-50 ng/mL (75-125 nmol/L) recommended for general health; higher targets (40-60 ng/mL) for specific conditions.